Information on TPP2

Basic details

Alt. symbols: TPPII

Approved name: tripeptidyl peptidase 2
Alt. names: tripeptidyl peptidase II

Location: 13q33.1: 102596958 - 102679958 (+)
Gene type: protein_coding, 29 transcripts.

Scores: LoFtool: 0.066600 | pLI: 0.99986319 | LOEUF: 0.263

HGNC: 12016

NCBI: 7174, RefSeq: NG_063544.1

Ensembl: ENSG00000134900.13

LRG_1341 | Status: public

OMIM: 190470

Expression | ProteinAtlas

Normal function

TPP2 encodes a ubiquitously expressed cytosolic protease involved in protein degradation. The enzyme removes tripeptides from the N-terminal end of longer peptides to help in the elimination of proteins downstream of the proteasome-ubiquitin degradation pathway. This also contributes to the maintenance of free amino acid pools for protein synthesis. TPP2 has also been implicated in stimulation of adipogenesis and the generation of thymic self-peptides and degradation of MHC class I epitopes, suggesting a role in immune function. It may be able to complement 26S proteasome function to some extent under conditions in which the latter is inhibited.

Dysfunction and disease

Biallelic mutations in TPP2 are associated with Immunodeficiency-78 with autoimmunity and developmental delay (IMD78) [MIM: 619220], an autosomal recessive systemic disorder characterized by immune dysregulation in the form of both immunodeficiency - featuring recurrent sinopulmonary or skin infections and increased susceptibility to bacterial, viral, and fungal infections - and autoimmunity, particularly cytopenias but also autoimmune hepatitis or thyroid disease, and CNS involvement with multi ple sclerosis-like sterile inflammation or vasculitis with stroke (PMID: 25414442, 30533531, 33586135). Laboratory studies show lymphopenia with advanced differentiation and premature senescence of CD8+ T cells and B cells; many patients show autoantibody production and some have hypergammaglobulinemia. Skin, hair and nail findings as well as developmental delays and variable intellectual disability may also be present. Many patients die prematurely, but successful hematopoietic bone marrow transplant may be curative. [Load More]

[Reviewed by Xiao P. Peng on 2021-06-07 10:09:38]

Associated conditions

Acronym Condition's_name MOI Mode_of_actionwww icon OMIM_ID No.cases
IMD78 Immunodeficiency 78 ARdict. icon 619220www icon 0 (0 fams)

Please mind that full curation (inclusion of all published patients) of this gene has not started yet. Please contact us if you want to volunteer.

Transcripts of TPP2

Name ENSEMBL_ID LRG_ID CCDS_ID MANE Transcript.type Exons Canonical CDS_length REFSEQ_ID
201 ENST00000376052.5 1 CCDS81777 Select protein_coding 30 Yes 5484 NM_001330588
202 ENST00000376065.8 CCDS9502 protein_coding 29 No 3931 NM_001367947,NM_003291

Published variants

Found 0 variants

Var.name Exon/Intron cDNA_pos. CDS_change Prot.change Var.type Var.class. Patients

Please mind that full curation (inclusion of all published variants) of this gene has not started yet. Please contact us if you want to volunteer.

Diagnostic pitfalls & paradigms

Considerations to take into account when analyzing this gene

Year Paradigm ⓘ PMID Notes
- Regions of Homology -
-Cryptic splicing-Unreported or not recorded in our DB.
-Uniparental disomy-Unreported or not recorded in our DB.
-Mosaicism-Unreported or not recorded in our DB.
-Incomplete penetrance-Unreported or not recorded in our DB.
-Di-/oligo-genic inheritance-Unreported or not recorded in our DB.
-Somatic reversion-Unreported or not recorded in our DB.

References linked to variants in TPP2

ID Year Title Journal PMID Variants

Phenotypic & functional assays available?

Find laboratories offering tests

Check